Marimed (MRMD) Amortization of Deferred Charges (2020 - 2025)
Marimed (MRMD) has disclosed Amortization of Deferred Charges for 5 consecutive years, with $43000.0 as the latest value for Q4 2025.
- Quarterly Amortization of Deferred Charges rose 191.49% to $43000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $109000.0 through Dec 2025, up 3533.33% year-over-year, with the annual reading at $73000.0 for FY2025, 29.81% down from the prior year.
- Amortization of Deferred Charges for Q4 2025 was $43000.0 at Marimed, up from $18000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $299000.0 in Q2 2023, with the low at -$301000.0 in Q4 2023.
- Average Amortization of Deferred Charges over 4 years is $24043.5, with a median of $18000.0 recorded in 2024.
- Peak annual rise in Amortization of Deferred Charges hit 800.0% in 2024, while the deepest fall reached 93.98% in 2024.
- Over 4 years, Amortization of Deferred Charges stood at $176522.0 in 2021, then plummeted by 270.52% to -$301000.0 in 2023, then skyrocketed by 84.39% to -$47000.0 in 2024, then skyrocketed by 191.49% to $43000.0 in 2025.
- According to Business Quant data, Amortization of Deferred Charges over the past three periods came in at $43000.0, $18000.0, and $18000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.